Eun Jung Park

6PUBLICATIONS
18CO-AUTHORS
Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Microbial geneticsNanotoxicology, health and safetyTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|May 11, 2026
PD-L1/Lag3 Bispecific Immune Checkpoint Blocking Nanocage Exhibits Potent Antitumor Activity beyond Dual Blockade of PD-L1 and Lag3.

|Sep 05, 2024
TIM-3 on myeloid cells promotes pulmonary inflammation through increased production of galectin-3.

Ki Sun Kim, Chanju Lee, Hyung-Seok Kim

|Aug 29, 2024
Galectin-9 Mediates the Functions of Microglia in the Hypoxic Brain Tumor Microenvironment.

Chanju Lee, Dahee Yu, Hyung-Seok Kim

|Dec 27, 2023
Immune Checkpoint-Blocking Nanocages Cross the Blood-Brain Barrier and Impede Brain Tumor Growth.

Minseong Kim, Hee Jung Yoon, Chanju Lee

|Feb 26, 2020
Glial TIM-3 Modulates Immune Responses in the Brain Tumor Microenvironment.

Hyung-Seok Kim, Chi Young Chang, Hee Jung Yoon

|Feb 06, 2019
Glial TLR2-driven innate immune responses and CD8+ T cell activation against brain tumor.

Chi Young Chang, Sae-Bom Jeon, Hee Jung Yoon

Pageof 1

Frequent Collaborators

4 joint publications

Sang Soo Kim

3 joint publications

Hyung-Seok Kim

3 joint publications

Hee Jung Yoon

2 joint publications

Byungheon Lee